- cafead Aug 29, 2024 at 11:32: AM
via Johnson & Johnson is asking the Food and Drug Administration to approve a new medicine the company believes can eventually be used to treat many diseases.
The initial submission covers use of the drug, called nipocalimab, in patients with generalized myasthenia gravis, J&J said Thursday. The condition causes a patient’s immune system to attack proteins that are needed for muscles to keep functioning properly. Symptoms can range from limb weakness to difficulty chewing, swallowing and breathing.
article source
The initial submission covers use of the drug, called nipocalimab, in patients with generalized myasthenia gravis, J&J said Thursday. The condition causes a patient’s immune system to attack proteins that are needed for muscles to keep functioning properly. Symptoms can range from limb weakness to difficulty chewing, swallowing and breathing.
article source